{"id":"https://openalex.org/W2402579232","doi":"https://doi.org/10.2147/ceor.s97319","title":"Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey","display_name":"Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-01","ids":{"openalex":"https://openalex.org/W2402579232","doi":"https://doi.org/10.2147/ceor.s97319","mag":"2402579232","pmid":"https://pubmed.ncbi.nlm.nih.gov/27284260","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4883807"},"language":"en","primary_location":{"id":"doi:10.2147/ceor.s97319","doi":"https://doi.org/10.2147/ceor.s97319","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ceor.s97319","pdf_url":"https://www.dovepress.com/getfile.php?fileID=30519","source":{"id":"https://openalex.org/S2736382696","display_name":"ClinicoEconomics and Outcomes Research","issn_l":"1178-6981","issn":["1178-6981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ClinicoEconomics and Outcomes Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2402579232"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=30519","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024860874","display_name":"Stefan Walzer","orcid":"https://orcid.org/0000-0002-6477-0106","observed_orcids":["https://orcid.org/0000-0002-6477-0106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefan Walzer","raw_affiliation_strings":["MArS Market Access and Pricing Strategy GmbH, Weil am Rhein, Loerrach, Germany; Health Care Management, State University Baden-Wuerttemberg, Loerrach, Germany","Health Care Management, State University Baden-Wuerttemberg, Loerrach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MArS Market Access and Pricing Strategy GmbH, Weil am Rhein, Loerrach, Germany; Health Care Management, State University Baden-Wuerttemberg, Loerrach, Germany","institution_ids":[]},{"raw_affiliation_string":"Health Care Management, State University Baden-Wuerttemberg, Loerrach, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025298042","display_name":"Clemente Ponzetti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clemente Ponzetti","raw_affiliation_strings":["Group Policlinic Monza, Alessandria, National Scientific Associazione Nazionale dei Medici delle Direzioni Ospedaliere (National Association of Hospital Physicians), Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Group Policlinic Monza, Alessandria, National Scientific Associazione Nazionale dei Medici delle Direzioni Ospedaliere (National Association of Hospital Physicians), Bologna, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002375382","display_name":"Monica Canciani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Canciani","raw_affiliation_strings":["Studio EmmEffe S.r.l, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Studio EmmEffe S.r.l, Milan, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087654635","display_name":"Massimo Farina","orcid":"https://orcid.org/0000-0002-5370-2693","observed_orcids":["https://orcid.org/0000-0002-5370-2693"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Massimo Farina","raw_affiliation_strings":["Studio EmmEffe S.r.l, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Studio EmmEffe S.r.l, Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088987711","display_name":"Sara Era","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113435","display_name":"Roche (Italy)","ror":"https://ror.org/01x544h30","country_code":"IT","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210113435"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Era","raw_affiliation_strings":["Roche S.p.a., Monza, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roche S.p.a., Monza, Italy","institution_ids":["https://openalex.org/I4210113435"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087654635"],"corresponding_institution_ids":[],"apc_list":{"value":2320,"currency":"USD","value_usd":2320},"apc_paid":{"value":2320,"currency":"USD","value_usd":2320},"fwci":7.9967,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.97001085,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"8","issue":null,"first_page":"227","last_page":"227"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5619999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.5619999766349792,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.3052000105381012,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13279","display_name":"Safe Handling of Antineoplastic Drugs","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/subcutaneous-administration","display_name":"subcutaneous administration","score":0.8299999833106995},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9200000166893005},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.8529999852180481},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.6050000190734863},{"id":"https://openalex.org/keywords/resource-utilization-health-care","display_name":"resource utilization (health care)","score":0.6190000176429749},{"id":"https://openalex.org/keywords/drug-wastage","display_name":"drug wastage","score":0.953000009059906},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8029999732971191},{"id":"https://openalex.org/keywords/italian-hospitals","display_name":"Italian hospitals","score":0.640999972820282},{"id":"https://openalex.org/keywords/real-world-impact","display_name":"real-world impact","score":0.4650000035762787},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.37299999594688416},{"id":"https://openalex.org/keywords/italy","display_name":"Italy","score":0.4359999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9312511682510376},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6395740509033203},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6068475246429443},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5368713736534119},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5120118260383606},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.45523977279663086},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4151732325553894},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36315029859542847},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3184572160243988}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.2147/ceor.s97319","doi":"https://doi.org/10.2147/ceor.s97319","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ceor.s97319","pdf_url":"https://www.dovepress.com/getfile.php?fileID=30519","source":{"id":"https://openalex.org/S2736382696","display_name":"ClinicoEconomics and Outcomes Research","issn_l":"1178-6981","issn":["1178-6981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ClinicoEconomics and Outcomes Research","raw_type":"journal-article"},{"id":"pmid:27284260","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27284260","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ClinicoEconomics and outcomes research : CEOR","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4883807","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4883807/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinicoecon Outcomes Res","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:8ff24e374d9f40f08d254b6764b4062e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8ff24e374d9f40f08d254b6764b4062e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ClinicoEconomics and Outcomes Research, Vol 2016, Iss Issue 1, Pp 227-233 (2016)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/27069","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/potential-resource-and-cost-saving-analysis-of-subcutaneous-versus-int-peer-reviewed-article-CEOR","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ceor.s97319","doi":"https://doi.org/10.2147/ceor.s97319","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ceor.s97319","pdf_url":"https://www.dovepress.com/getfile.php?fileID=30519","source":{"id":"https://openalex.org/S2736382696","display_name":"ClinicoEconomics and Outcomes Research","issn_l":"1178-6981","issn":["1178-6981"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ClinicoEconomics and Outcomes Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2402579232.pdf","grobid_xml":"https://content.openalex.org/works/W2402579232.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2049071559","https://openalex.org/W2074831318","https://openalex.org/W2127287298","https://openalex.org/W4230263812"],"related_works":["https://openalex.org/W4414105359","https://openalex.org/W2074831318","https://openalex.org/W2805001001","https://openalex.org/W3024246027","https://openalex.org/W2980141953","https://openalex.org/W2330930594","https://openalex.org/W2890178981","https://openalex.org/W2773709250","https://openalex.org/W2228881923","https://openalex.org/W2625991865"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Subcutaneous":[1],"versions":[2],"of":[3,35,80,102,168,240,275,317,321,336,349],"different":[4,69],"oncology":[5],"therapies":[6,338],"have":[7,21,332],"been":[8,23],"available":[9,339],"for":[10,12,38,141,164,202,211,286,344],"patients":[11,326],"a":[13,49,103,165,311,318,345],"few":[14],"years,":[15],"yet":[16],"patient-relevant":[17],"and":[18,65,84,206,245,280,296,305,323,327,351],"hospital":[19],"benefits":[20],"not":[22],"assessed":[24],"in":[25,42,52,74,90,108,111,154,235,252,265,307,329,340],"real":[26,76],"life.":[27],"METHODS:":[28],"In":[29,190],"order":[30,91],"to":[31,44,61,92,115,161,300],"analyze":[32,62],"the":[33,45,63,75,87,99,125,138,195,203,207,238,268,287,315,333,341],"impact":[34],"subcutaneous":[36,126,186,230,269,279,284,301,319],"administrations":[37],"rituximab":[39,153,278,304,322],"or":[40],"trastuzumab":[41,283,306],"comparison":[43],"respective":[46],"intravenous":[47,177,223,258],"mode":[48,127],"primary":[50,58],"research":[51],"Italy":[53,112,308],"was":[54,82,243,255],"executed.":[55],"The":[56,78,145],"study's":[57],"objectives":[59],"were":[60,113,261],"resource":[64,295],"cost":[66,273,297],"implications":[67],"from":[68],"perspectives":[70],"(patient,":[71],"medical":[72,241],"staff)":[73],"world.":[77],"route":[79],"administration":[81,270,285,302],"discussed":[83],"aligned":[85],"with":[86,124,152,257,272,277,282,303],"participating":[88],"centers":[89,107],"capture":[93],"all":[94],"relevant":[95],"therapy":[96],"parts.":[97],"After":[98],"successful":[100],"execution":[101],"pilot":[104],"study":[105],"19":[106],"six":[109],"regions":[110],"recruited":[114],"participate.":[116],"RESULTS:":[117],"Significant":[118],"time":[119,133,136,147,196,209,239,350],"savings":[120,274,298],"might":[121,198,214],"be":[122,199,215,248],"achieved":[123],"through":[128,267],"significantly":[129],"lower":[130],"patient":[131,171,212],"preparation":[132,173,213,219],"including":[134],"less":[135],"preparing":[137],"actual":[139],"dosing":[140],"each":[142],"individual":[143],"patient.":[144],"total":[146,208],"difference":[148],"is":[149],"3.3":[150,200],"hours":[151,163,176,185,201,217,222,229],"hematology":[155],"(non-Hodgkin's":[156],"lymphoma),":[157],"which":[158],"adds":[159],"up":[160],"23.55":[162],"full":[166,288],"course":[167],"treatment":[169,289],"per":[170],"(overall":[172,218],"time:":[174,220],"40.1":[175],"[95%":[178,187,224,231],"confidence":[179],"interval":[180],"(CI):":[181],"\u00b10.47]":[182],"vs":[183,227],"16.6":[184],"CI:":[188,225,232],"\u00b10.2]).":[189],"early":[191],"breast":[192],"cancer":[193],"(trastuzumab),":[194],"saving":[197,210],"first":[204],"cycle":[205],"17.2":[216],"38.8":[221],"\u00b19.42]":[226],"21.6":[228],"\u00b19.9]).":[233],"Furthermore,":[234],"both":[236],"settings,":[237],"staff":[242],"reduced":[244],"could":[246],"hence":[247],"used":[249],"elsewhere.":[250],"Finally,":[251],"case":[253],"wastage":[254,266],"experienced":[256],"therapies,":[259],"there":[260],"potential":[262],"significant":[263,294],"reductions":[264],"(93%-100%)":[271],"\u20ac6,057":[276],"\u20ac28,399":[281],"course.":[290],"CONCLUSION:":[291],"There":[292],"are":[293],"due":[299],"based":[309],"on":[310],"systematic":[312],"survey.":[313],"With":[314],"availability":[316],"use":[320,348],"trastuzumab,":[324],"hospitals,":[325],"payers":[328],"general":[330],"still":[331],"current":[334],"standard":[335],"care":[337],"approved":[342],"indications":[343],"more":[346],"efficient":[347],"resources.":[352]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2402579232","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
